C 9 H 13 N 3 O 2 S, monoclinic, P21/c (no. 14), a = 8.0984(4) Å, b = 17.3203(10) Å, c = 9.6802(4) Å, β = 124.031(3)°, V = 1125.26(10) Å 3 , Z = 4, Rgt(F) = 0.0504, wR ref (F 2 ) = 0.1275, T = 293(2) K.
Experimental details
Cell refinement and data reduction were carried out by Bruker SAINT, SHELXT [1, 2] .
Comment
Benzenesulfonamides (ArSO 2 NH 2 ) incorporating aromatic and heterocyclic ring systems are an important group of compounds, which have a wide range of biological activity such as anti-inflammatory, COX-1/2 inhibiting activity, inhibitors of the metalloenzyme carbonic anhydrase, and antitumor activities [3] [4] [5] [6] [7] [8] . Recently, the synthesis of N-sulfonylformamidines has been reported through condensation of formamides and versatile sulfonamides using thionylchloride in the presence of chloroform as solvent [9] . The title compound was synthesized and reported according to method described by Silva, et al. [10] . Detailed synthetic studies indicate that this procedure gives the title compound.
The asymmetric unit of the title compound contains one independent molecule. The bond length between N1-C7 is 1.296(3) Å which indicates that it is a double bond, compared to 1.320(3) Å between N2-C7. Bond lengths and angles of the title molecule are in the expected ranges [11] . The molecules pack in the crystal structure via two strong classical intermolecular hydrogen bonds, N3-H2· · · N1 i and N3-H3· · · O1 ii in addition to one non-classical hydrogen bond C9-H9B· · · O2 iii . The H· · · A distances are 2.31, 2.14 and 2.47 Å, respectively and the angles are 170, 164 and 161°, respectively. Symmetry codes: (i) x − 1, −y − 3/2, z − 1/2; (ii) x − 1, y, z − 1; (iii) x + 1, y, z.
